Literature DB >> 8468522

Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease.

V V Tertov1, A N Orekhov, I A Sobenin, J D Morrisett, A M Gotto, J G Guevara.   

Abstract

Low density lipoprotein (LDL) from patients with coronary heart disease (CHD) caused 78-286% increase in accumulation of cholesterol in human aortic subendothelial cells compared to 2-17% caused by LDL from normal subjects. Ricin-Sepharose affinity chromatography was used to separate LDL into two subfractions, one sialic acid-rich (SAR) and the other sialic acid-poor (SAP). SAP-LDL from CHD patients caused 156-307% increase in accumulation of cellular cholesterol, whereas SAR-LDL from these patients caused only 14-21% increase. SAP-LDL from normal healthy subjects caused 50-86% increased accumulation, whereas their SAR-LDL induced only 2-12% increase. Carbohydrate analysis of SAP-LDL protein isolated from four CHD patients revealed mean values of 59, 25, 61, and 11 nmoles of N-acetyl glucosamine, galactose, mannose, and sialic acid per mg protein, respectively. Mean values for SAR-LDL protein from these patients were 59, 31, 77, and 24 nmol/mg protein, respectively. Analysis of SAP-LDL protein from four normal healthy subjects indicated respective mean values of 58, 29, 72, and 22 nmol/mg, whereas SAR-LDL protein from normals contained 59, 29, 72, and 29 nmol/mg. The carbohydrate content of LDL lipids represents about 25% of the total carbohydrate present in the lipoprotein. The mean values for SAP-LDL lipids from four CHD patients were about 2, 2, 18, 18, and 2 nmol/mg protein for N-acetyl galactosamine, N-acetyl glucosamine, galactose, glucose, and sialic acid, respectively. The mean values for SAR-LDL lipids from these patients were 3, 4, 34, 41, and 5 nmol/mg, respectively. Analysis of SAP-LDL lipids from four normal healthy subjects indicated respective mean values of 4, 6, 30, 31, and 3 nmol/mg, whereas SAR-LDL lipids from these subjects contained 6, 9, 41, 46, and 7 nmol/mg. These results suggest that the different biological properties of SAR-LDL and SAP-LDL are related to their different carbohydrate compositions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468522

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

Review 1.  Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov.

Authors:  Victor Glanz; Evgeny E Bezsonov; Vladislav Soldatov; Alexander N Orekhov
Journal:  Biomedicines       Date:  2022-05-19

Review 2.  Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy.

Authors:  C M Ballantyne; L Chan; J Guevara; J D Morrisett; M P Mims; A M Gotto
Journal:  Tex Heart Inst J       Date:  1994

3.  A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL.

Authors:  Ana Reis; Alisa Rudnitskaya; Gavin J Blackburn; Norsyahida Mohd Fauzi; Andrew R Pitt; Corinne M Spickett
Journal:  J Lipid Res       Date:  2013-05-13       Impact factor: 5.922

4.  The interaction of plasma sialylated and desialylated lipoproteins with collagen from the intima and media of uninvolved and atherosclerotic human aorta.

Authors:  Igor A Sobenin; Igor V Suprun; Vasiliy P Karagodin; Alexander S Feoktistov; Alexandra A Melnichenko; Alexander N Orekhov
Journal:  J Lipids       Date:  2011-11-17

5.  Reduced apolipoprotein glycosylation in patients with the metabolic syndrome.

Authors:  Olga V Savinova; Kristi Fillaus; Linhong Jing; William S Harris; Gregory C Shearer
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

6.  Carbohydrate composition of circulating multiple-modified low-density lipoprotein.

Authors:  Emile R Zakiev; Igor A Sobenin; Vasily N Sukhorukov; Veronika A Myasoedova; Ekaterina A Ivanova; Alexander N Orekhov
Journal:  Vasc Health Risk Manag       Date:  2016-10-14

Review 7.  Lipoprotein sialylation in atherosclerosis: Lessons from mice.

Authors:  Liming Yu; Jun Peng; Chieko Mineo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

Review 8.  Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value.

Authors:  Igor A Sobenin; Jukka T Salonen; Andrey V Zhelankin; Alexandra A Melnichenko; Jari Kaikkonen; Yuri V Bobryshev; Alexander N Orekhov
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

Review 9.  Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.

Authors:  Alexander N Orekhov; Yuri V Bobryshev; Igor A Sobenin; Alexandra A Melnichenko; Dimitry A Chistiakov
Journal:  Int J Mol Sci       Date:  2014-07-21       Impact factor: 5.923

10.  Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First?

Authors:  Alexander N Orekhov; Vasily N Sukhorukov; Nikita G Nikiforov; Marina V Kubekina; Igor A Sobenin; Kathy K Foxx; Sergey Pintus; Philip Stegmaier; Daria Stelmashenko; Alexander Kel; Anastasia V Poznyak; Wei-Kai Wu; Artem S Kasianov; Vsevolod Y Makeev; Ichiro Manabe; Yumiko Oishi
Journal:  Int J Mol Sci       Date:  2020-04-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.